|
CANX expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.6251444634463E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.62925228863742E-12 |
| Normal-vs-Stage2 |
2.016300E-04 |
| Normal-vs-Stage3 |
7.52900000011714E-07 |
| Normal-vs-Stage4 |
1.864090E-03 |
| Stage1-vs-Stage2 |
7.737000E-01 |
| Stage1-vs-Stage3 |
3.698200E-01 |
| Stage1-vs-Stage4 |
3.995900E-02 |
| Stage2-vs-Stage3 |
4.094000E-01 |
| Stage2-vs-Stage4 |
1.128170E-01 |
| Stage3-vs-Stage4 |
2.917800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
<1E-12 |
| Normal-vs-AfricanAmerican |
9.372400E-01 |
| Normal-vs-Asian |
2.457600E-01 |
| Caucasian-vs-AfricanAmerican |
7.62570007140084E-11 |
| Caucasian-vs-Asian |
4.144200E-01 |
| AfricanAmerican-vs-Asian |
1.462360E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.34114941374719E-13 |
| Normal-vs-Female |
1.81760051454205E-10 |
| Male-vs-Female |
8.262400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.098300E-02 |
| Normal-vs-Age(41-60Yrs) |
2.33519870107557E-11 |
| Normal-vs-Age(61-80Yrs) |
5.07383024483943E-12 |
| Normal-vs-Age(81-100Yrs) |
6.697500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.742400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.456400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.912210E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.547600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.739600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.718200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.340300E-02 |
| Normal-vs-Grade 2 |
2.78665979180914E-14 |
| Normal-vs-Grade 3 |
7.72070185561802E-11 |
| Normal-vs-Grade 4 |
9.943700E-03 |
| Grade 1-vs-Grade 2 |
6.651800E-01 |
| Grade 1-vs-Grade 3 |
8.885200E-01 |
| Grade 1-vs-Grade 4 |
4.817200E-01 |
| Grade 2-vs-Grade 3 |
4.118400E-01 |
| Grade 2-vs-Grade 4 |
1.721870E-02 |
| Grade 3-vs-Grade 4 |
7.962000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
<1E-12 |
| Normal-vs-ccB subtype |
1.79779999998075E-06 |
| ccA subtype-vs-ccB subtype |
2.763600E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.42428299657149E-12 |
| Normal-vs-N1 |
2.051600E-01 |
| N0-vs-N1 |
4.792200E-01 |
|
|
